Latest Thrombolysis Stories

May is National Stroke Awareness Month. Learn the symptoms and act quickly at first signs of stroke. Trenton, NJ (PRWEB) May 17, 2013 Seeking prompt emergency care at the first sign of stroke is more important than ever because new interventions can open clots and restore blood flow to the brain, often reducing or preventing permanent damage. A new generation of mechanical blood clot retrieval devices, some available in just the past year, is making emergency interventions more effective,...

A new study from the University of Cincinnati (UC) College of Medicine has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA). The novel delivery method involved trapping plasmin into bubble-like liposomes, delivering them to the clot intravenously and bursting it via ultrasound. That method is necessary, says UC associate professor of...

Certified Primary Stroke Centers are three times more likely to administer clot-busting treatment for strokes than non-certified centers, reports a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania. The study, published in the Journal of the American Heart Association, looked at a wide sample of hospitals across the United States, and provides insight into practice across the US health care system as experts examine ways to increase the use of this...

Stroke patients are three times more likely to receive clot-busting medication if treated at a certified stroke center, according to a study in the Journal of the American Heart Association. Intravenous tissue plasminogen activator (tPA) is the only drug approved by the Food and Drug Administration for emergency treatment for people who have ischemic (clot-caused) stroke. The durg can reduce stroke disability. "The stroke center concept has rapidly taken off, and this data demonstrates...

Award demonstrates Saint Luke's Neuroscience Institute's commitment to quality care for stroke patients KANSAS CITY, Mo., March 22, 2013 /PRNewswire-USNewswire/ -- The Saint Luke's Neuroscience Institute (SLNI) has received the American Heart Association/American Stroke Association's Get With The Guidelines(®)-Stroke Gold Plus Quality Achievement Award. The award recognizes SLNI's commitment and success in implementing excellent care for stroke patients, according to evidence-based...

SINGAPORE, March 19, 2013 /PRNewswire/ -- Authors of a medical paper published in this month's Cerebrovascular Diseases journal found that NeuroAiD(TM), developed by Moleac, significantly improves patients' independence after suffering a stroke compared to other control groups. During the studies stroke patients taking NeuroAiD(TM) were twice as likely able to take care of themselves and speak freely. The study also showed that NeuroAiD(TM) improved patients' chances of performing...

When someone has a stroke, time equals brain. The longer a stroke is left untreated, the more brain tissue is lost. Since the only proven treatment — a clot-busting drug — works in less than half of patients, stroke physicians had high hopes for a mechanical device that could travel through the blocked blood vessel to retrieve or break up the clot, restoring blood flow to the brain. But in a recently completed multi-site trial in which UCLA served as the clinical coordinating center,...

Rate of brain hemorrhage in stroke patients given tPA isn't meaningfully higher Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots. But when one of them suffers a stroke caused by a clot in their brain, some emergency teams might hesitate to give a powerful clot-busting medication called tPA -- for fear that the combination of drugs might cause dangerous brain bleeding. Now, a University of...

STREAM trial: Treatment with tenecteplase before hospital transfer benefits some A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. "Drug therapy before transfer is at least as effective as [angioplasty], and an urgent catheterization was avoided in two-thirds of patients," said Frans Van de Werf, MD, PhD, professor of cardiology...

NeuroCareTech introduces First iPhone app designed by a doctor for doctors’ clinical use to help rapidly determine stroke patient eligibility for life-saving treatment called tPA. BrainAttack App processes eligibility data accurately and more quickly, while reducing to minutes the time required by emergency room physicians to determine tPA eligibility Chicago, IL and Dallas, TX (PRWEB) February 13, 2013 Emergency room staff, neurologists and other mid-level health care providers racing...